Meeting Abstract


DOI :10.26650/JARHS2021-1133643   IUP :10.26650/JARHS2021-1133643    Full Text (PDF)

EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT

Ömer Küçük

Soy intake has been associated with a lower risk of prostate cancer. Soybeans contain isoflavones, genistein, daidzein and glycitein, which have shown anti-cancer effects in cell culture and animal studies. Recently clinical trials of soy isoflavones in humans have also shown promising results. Soy isoflavones have anti-oxidant and anti-inflammatory properties which may be important for their anticancer effects. In addition, recent studies have shown significant epigenetic effects of soy isoflavones. DNA methylation and histone acetylation has been reported to be modified by genistein. Therefore, genistein may have effects similar to the commonly used cancer drugs, demethylating agent 5-azacytidine and histone deacetylase inhibitor drug Vorinostat. Thus, combining genistein with cancer chemotherapeutic agents may have potential benefits. Furthermore, radiation therapy and conventional cancer therapeutic agents activate NF-kappa-B resulting in resistance to chemotherapy and radiation. Genistein is a potent inhibitor of NF-kappa-B, and thereby may sensitize cancer cells to chemotherapy and radiation therapy. While sensitizing cancer cells chemotherapy and radiation, at the same time genistein may protect the normal tissues from adverse effects of radiation chemotherapy which are due to their oxidative and inflammatory effects. Clinical trials investigating the chemotherapy and radiation therapy potentiating as well as toxicity reducing effects of soy isoflavones are warranted. In addition, adverse effects of androgen deprivation therapy, such as metabolic syndrome, hypertension, diabetes and cardiovascular disease could also be potentially prevented by soy isoflavones. 


PDF View

References

    Citations

    Copy and paste a formatted citation or use one of the options to export in your chosen format


    EXPORT



    APA

    Küçük, Ö. (2022). EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT. Journal of Advanced Research in Health Sciences, 5(1), 19-19. https://doi.org/10.26650/JARHS2021-1133643


    AMA

    Küçük Ö. EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT. Journal of Advanced Research in Health Sciences. 2022;5(1):19-19. https://doi.org/10.26650/JARHS2021-1133643


    ABNT

    Küçük, Ö. EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT. Journal of Advanced Research in Health Sciences, [Publisher Location], v. 5, n. 1, p. 19-19, 2022.


    Chicago: Author-Date Style

    Küçük, Ömer,. 2022. “EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT.” Journal of Advanced Research in Health Sciences 5, no. 1: 19-19. https://doi.org/10.26650/JARHS2021-1133643


    Chicago: Humanities Style

    Küçük, Ömer,. EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT.” Journal of Advanced Research in Health Sciences 5, no. 1 (Feb. 2024): 19-19. https://doi.org/10.26650/JARHS2021-1133643


    Harvard: Australian Style

    Küçük, Ö 2022, 'EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT', Journal of Advanced Research in Health Sciences, vol. 5, no. 1, pp. 19-19, viewed 24 Feb. 2024, https://doi.org/10.26650/JARHS2021-1133643


    Harvard: Author-Date Style

    Küçük, Ö. (2022) ‘EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT’, Journal of Advanced Research in Health Sciences, 5(1), pp. 19-19. https://doi.org/10.26650/JARHS2021-1133643 (24 Feb. 2024).


    MLA

    Küçük, Ömer,. EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT.” Journal of Advanced Research in Health Sciences, vol. 5, no. 1, 2022, pp. 19-19. [Database Container], https://doi.org/10.26650/JARHS2021-1133643


    Vancouver

    Küçük Ö. EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT. Journal of Advanced Research in Health Sciences [Internet]. 24 Feb. 2024 [cited 24 Feb. 2024];5(1):19-19. Available from: https://doi.org/10.26650/JARHS2021-1133643 doi: 10.26650/JARHS2021-1133643


    ISNAD

    Küçük, Ömer. EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT”. Journal of Advanced Research in Health Sciences 5/1 (Feb. 2024): 19-19. https://doi.org/10.26650/JARHS2021-1133643



    TIMELINE


    Published Online09.08.2022

    LICENCE


    Attribution-NonCommercial (CC BY-NC)

    This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


    SHARE




    Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.